Doximity: Slowing Sales And EBITDA Growth
Source: SeekingAlpha
2025-07-23 15:35:08 ET
Today, I put Doximity, Inc. ( DOCS ) in the spotlight. The stock is down nearly 25% from its recent highs in February. The company has seen tremendous revenue growth over its history and has a rock-solid balance sheet as well. Is the stock in the ' buy zone ' yet? An analysis follows below....
Read the full article on Seeking Alpha
For further details see:
Doximity: Slowing Sales And EBITDA Growth
Doximity Inc. Class A
NASDAQ: DOCS
DOCS Trading
1.84% G/L:
$24.655 Last:
135,718 Volume:
$24.15 Open:
DOCS Latest News
February 23, 2026 01:35:00 am
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.
DOCS Stock Data
$5,029,624,926
180,645,361
N/A
184
N/A
Healthcare Providers & Services
Healthcare
US
San Francisco
